GLI1 and acute myeloid leukemia: Another proposed mechanisms is induction of the glucuronidation in acute myeloid leukemia (AML), where GLI1 is sufficient to drive UGT1A-dependent glucuronidation of ribavirin and cytarabine, leading to resistance [300].